NFX1
Transcriptional repressor NF-X1
Also known as: MGC20369, NFX1_HUMAN, NFX2, TEG-42, Tex42
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12986
- Gene
- NFX1
- Ensembl
- ENSG00000086102
- Chromosome
- 9
- Canonical length
- 1120 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli,Plasma membrane,Cytosol
OverviewNCBI Gene
MHC class II gene expression is controlled primarily at the transcriptional level by transcription factors that bind to the X and Y boxes, two highly conserved elements in the proximal promoter of MHC class II genes. The protein encoded by this gene is a transcriptional repressor capable of binding to the conserved X box motif of HLA-DRA and other MHC class II genes in vitro. The protein may play a role in regulating the duration of an inflammatory response by limiting the period in which class II MHC molecules are induced by IFN-gamma. Three alternative splice variants, each of which encodes a different isoform, have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1120 residues, UniProt reviewed canonical sequence.
>Q12986|NFX1
1 MAEAPPVSGT FKFNTDAAEF IPQEKKNSGL NCGTQRRLDS NRIGRRNYSS PPPCHLSRQV
61 PYDEISAVHQ HSYHPSGSKP KSQQTSFQSS PCNKSPKSHG LQNQPWQKLR NEKHHIRVKK
121 AQSLAEQTSD TAGLESSTRS ESGTDLREHS PSESEKEVVG ADPRGAKPKK ATQFVYSYGR
181 GPKVKGKLKC EWSNRTTPKP EDAGPESTKP VGVFHPDSSE ASSRKGVLDG YGARRNEQRR
241 YPQKRPPWEV EGARPRPGRN PPKQEGHRHT NAGHRNNMGP IPKDDLNERP AKSTCDSENL
301 AVINKSSRRV DQEKCTVRRQ DPQVVSPFSR GKQNHVLKNV ETHTGSLIEQ LTTEKYECMV
361 CCELVRVTAP VWSCQSCYHV FHLNCIKKWA RSPASQADGQ SGWRCPACQN VSAHVPNTYT
421 CFCGKVKNPE WSRNEIPHSC GEVCRKKQPG QDCPHSCNLL CHPGPCPPCP AFMTKTCECG
481 RTRHTVRCGQ AVSVHCSNPC ENILNCGQHQ CAELCHGGQC QPCQIILNQV CYCGSTSRDV
541 LCGTDVGKSD GFGDFSCLKI CGKDLKCGNH TCSQVCHPQP CQQCPRLPQL VRCCPCGQTP
601 LSQLLELGSS SRKTCMDPVP SCGKVCGKPL PCGSLDFIHT CEKLCHEGDC GPCSRTSVIS
661 CRCSFRTKEL PCTSLKSEDA TFMCDKRCNK KRLCGRHKCN EICCVDKEHK CPLICGRKLR
721 CGLHRCEEPC HRGNCQTCWQ ASFDELTCHC GASVIYPPVP CGTRPPECTQ TCARVHECDH
781 PVYHSCHSEE KCPPCTFLTQ KWCMGKHEFR SNIPCHLVDI SCGLPCSATL PCGMHKCQRL
841 CHKGECLVDE PCKQPCTTPR ADCGHPCMAP CHTSSPCPVT ACKAKVELQC ECGRRKEMVI
901 CSEASSTYQR IAAISMASKI TDMQLGGSVE ISKLITKKEV HQARLECDEE CSALERKKRL
961 AEAFHISEDS DPFNIRSSGS KFSDSLKEDA RKDLKFVSDV EKEMETLVEA VNKGKNSKKS
1021 HSFPPMNRDH RRIIHDLAQV YGLESVSYDS EPKRNVVVTA IRGKSVCPPT TLTGVLEREM
1081 QARPPPPIPH HRHQSDKNPG SSNLQKITKE PIIDYFDVQDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NFX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 36 nTPM
- liver: 26 nTPM
- tongue: 25 nTPM
- thymus: 25 nTPM
- skin: 24 nTPM
- tonsil: 24 nTPM
Single-cell type
- myonuclei: 280 nCPM
- pdcs: 201 nCPM
- somatotrophs: 182 nCPM
- adrenal cortex cells: 181 nCPM
- lactotrophs: 167 nCPM
- pituicytes/fscs: 160 nCPM
Immune cell
- basophil: 36 nTPM
- plasmacytoid DC: 16 nTPM
- memory B-cell: 13 nTPM
- naive CD8 T-cell: 12 nTPM
- naive CD4 T-cell: 12 nTPM
- memory CD8 T-cell: 11 nTPM
Brain region
- cerebellum: 59 nTPM
- white matter: 53 nTPM
- choroid plexus: 50 nTPM
- hypothalamus: 48 nTPM
- cerebral cortex: 48 nTPM
- basal ganglia: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- inflammatory response
- negative regulation of MHC class II biosynthetic process
- negative regulation of transcription by RNA polymerase II
- protein autoubiquitination
- protein ubiquitination
- transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- ubiquitin protein ligase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, NF-X1-type
- R3H domain
- Zinc finger, RING-type
- Zinc finger, PHD-finger
- Transcription factor NFX1 family
- R3H domain superfamily
- NF-X1 type zinc finger
- R3H domain
- Transcriptional repressor NF-X1, R3H domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NFX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NFX1 as an antibody target. Whether an autoantibody or antibody against NFX1 could matter depends on whether native NFX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NFX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NFX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...